Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Addex Therapeutics
< Previous
1
2
3
Next >
Addex Regains Nasdaq Listing Compliance
November 08, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Announces Participation in the Bio-Europe 2023 Conference
November 02, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Completes ADS Ratio Change
October 20, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Announces Plan to Implement ADS Ratio Change
October 06, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
September 20, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024
September 05, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex’s Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain
September 04, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Reports 2023 Half Year and Second Quarter Financial Results and Provides Corporate Update
August 10, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Therapeutics to Release Half-Year 2023 Financial Results and Host Conference Call on August 10, 2023
August 04, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex GABAB Positive Allosteric Modulator Program to Receive Additional CHF2.7 Million from Indivior in Extended Substance Use Disorder Research Collaboration
August 03, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex mGlu2PAM Demonstrates Potential in Substance Use Disorder
July 24, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Increases Issued Share Capital to Create Treasury Shares
June 15, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Shareholders Approve All Resolutions at Annual General Meeting
June 01, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
May 18, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Reports Q1 2023 Financial Results and Provides Corporate Update
May 11, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s Independent Interim Review Committee Recommends Continuing Study
May 10, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Convenes Annual General Meeting 2023
May 05, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May 11, 2023
May 04, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Completes $5.0 Million Equity Financing
April 05, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson’s Disease
April 04, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Raises $5.0 Million in Equity Financing
April 03, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Reports Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Therapeutics to Release Full-Year 2022 Financial Results and Host Conference Call on March 30, 2023
March 28, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Announces Upcoming Conferences it will participate for H1 2023
March 16, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Regains Nasdaq Listing Compliance
February 09, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1
February 06, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex Provides Corporate Update and Financial Guidance
January 19, 2023
From
Addex Therapeutics
Via
GlobeNewswire
Addex and Indivior Extend Research Term of Substance Use Disorder GABAB Positive Allosteric Modulator Discovery Collaboration
December 08, 2022
From
Addex Therapeutics
Via
GlobeNewswire
Addex Reports Q3 2022 Financial Results and Provides Corporate Update
November 11, 2022
From
Addex Therapeutics
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today